Eva Pardina
YOU?
Author Swipe
View article: A Potential Ratio for Detecting Subclinical Atherosclerosis: Insight into Advanced NMR Lipid Profiles in Severe Obesity
A Potential Ratio for Detecting Subclinical Atherosclerosis: Insight into Advanced NMR Lipid Profiles in Severe Obesity Open
Individuals with severe obesity (SO) are at a high risk of developing cardiovascular disease, but traditional lipid parameters are insufficient for accurately assessing the risk. This study aims to investigate the advanced characteristics …
View article: Circulating miRNAs as Biomarkers of Subclinical Atherosclerosis Associated with Severe Obesity before and after Bariatric Surgery
Circulating miRNAs as Biomarkers of Subclinical Atherosclerosis Associated with Severe Obesity before and after Bariatric Surgery Open
Introduction: Severe obesity results in high cardiovascular risk (CVR), increasing morbidity, and mortality. New and improved methods are needed to detect cardiovascular diseases rapidly in severe obesity. microRNAs (miRNAs) has shown prom…
View article: Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis
Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis Open
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), a leading cause of chronic liver disease, has increased worldwide along with the epidemics of obesity and related dysmetabolic conditions characterized by …
View article: P168 Specialized pro-resolving lipid mediator Resolvin D1 and omega 6 dihomo-γ-linolenic acid are unable to solve inflammation in the creeping fat of patients with severe postoperative recurrence in Crohn's disease
P168 Specialized pro-resolving lipid mediator Resolvin D1 and omega 6 dihomo-γ-linolenic acid are unable to solve inflammation in the creeping fat of patients with severe postoperative recurrence in Crohn's disease Open
Background The ω3 derivate resolvin D1 (RvD1), and the ω6 dihomo-γ-linolenic acid (DGLA) prevent collateral damage by overcoming inflammation and enhancing microbial clearance. In Crohn's disease, the mesenteric adipose tissue becomes infl…
View article: Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury
Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury Open
Despite significant advances in cancer therapeutics, chemotherapy remains the cornerstone of treatment for many tumors. Importantly, however, chemotherapy-induced toxicity, including hepatotoxicity, can lead to the interruption or disconti…
View article: Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity
Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity Open
Severe obesity (SO) can accelerate atherosclerosis and the onset of acute cardiovascular events. The diagnosis of atherosclerosis in the context of a high body mass index (BMI) can be challenging, making the identification of biomarkers cl…
View article: P023 Immune-metabolic profiles of creeping fat in relation to degree of severity in Crohn’s disease postsurgical recurrence.
P023 Immune-metabolic profiles of creeping fat in relation to degree of severity in Crohn’s disease postsurgical recurrence. Open
Background Crohn’s disease (CD) is an inflammatory bowel disease (IBD) of complex etiology that normally requires bowel resection. However, many patients suffer from post-operative recurrence (POR) within one year. Here, the inflammatory a…
View article: Adjustable Gastric Banding Conversion to One Anastomosis Gastric Bypass: Data Analysis of a Multicenter Database
Adjustable Gastric Banding Conversion to One Anastomosis Gastric Bypass: Data Analysis of a Multicenter Database Open
View article: The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease
The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease Open
In the last decade, there has been growing interest in the pathological involvement of hypertrophic mesenteric fat attached to the serosa of the inflamed intestinal segments involved in Crohn’s disease [CD], known as creeping fat. In spite…
View article: Conversion of Adjustable Gastric Banding to Roux-en-Y Gastric Bypass in One or Two Steps: What Is the Best Approach? Analysis of a Multicenter Database Concerning 832 Patients
Conversion of Adjustable Gastric Banding to Roux-en-Y Gastric Bypass in One or Two Steps: What Is the Best Approach? Analysis of a Multicenter Database Concerning 832 Patients Open
View article: CCDC 1984596: Experimental Crystal Structure Determination
CCDC 1984596: Experimental Crystal Structure Determination Open
View article: SEROHEMATIC GROUP DISCREPANCY IN COVID-19 POSITIVE PATIENTS
SEROHEMATIC GROUP DISCREPANCY IN COVID-19 POSITIVE PATIENTS Open
View article: Comparison between Capillary and Venous Blood Sampling for Lipoprotein Lipase Activity Measuring
Comparison between Capillary and Venous Blood Sampling for Lipoprotein Lipase Activity Measuring Open
View article: Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese
Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese Open
Background & aims: To study the origin of fat excess in the livers of morbidly obese (MO) individuals, we analysed lipids and lipases in both plasma and liver and genes involved in lipid transport, or related with, in that organ. Methods: …
View article: Hepatic and visceral adipose tissue 11β<scp>HSD</scp>1 expressions are markers of body weight loss after bariatric surgery
Hepatic and visceral adipose tissue 11β<span>HSD</span>1 expressions are markers of body weight loss after bariatric surgery Open
Objective Cortisolemia and 11βHSD1 in liver and adipose tissue are altered in obesity. However, their participation in the development of obesity remains unclear. This study analyzed these parameters in the transition from morbid to type 1…